INTRODUCTION
Psoriasis is a chronic, non-contagious, of universal occurrence, inflammatory disease that affects skin and joints. 1, 2 In the skin, it is characterized by erythematous-squamous plaques, affecting mainly extensor surfaces of the limbs and scalp. The disorder is recurrent and has a prevalence of 2-3% in the world population. 2, 3 Its etiology is multifactorial, in which genetic and environmental factors lead to immunological dysfunction and characteristic inflammation. 1, 2 Psoriasis has an unknown cause, but some studies show a close correlation between disease and metabolic syndrome and cardiovascular diseases. 4, 5, 6, 7 Several microorganisms have also been identified as intensifiers of the disease. 8 Recently, it has been suggested that Helicobacter pylori infection may contribute as a trigger for the development of psoriasis. 9, 10 H. pylori has infected the human species for more than 50,000 years. 11 It was isolated in 1982 by Barry Marshall and Robin
Warren. It is a gram-negative, microaerophilic, helicoidal bacterium that inhabits the gastric mucosa, and can cause peptic ulcer, gastritis and gastric cancer. 12, 13 In less developed countries, infection is acquired early in childhood through oral-fecal contact. Its prevalence rate reaches 80-100% in adolescence and, if untreated, it persists throughout life. In contrast, in more developed countries, bacterial infection is acquired later in childhood or adolescence, and it is cured in about 10% of cases, reaching a prevalence peak of 50-70% during adulthood. 13 The objective of this study was to determine the profile of seroprevalence of Helicobacter pylori in patients with clinical diagnosis of psoriasis treated in a period of six months at Ambulatório Amélio Marques of the Federal University of Uberlândia and to evaluate its association with the severity of the disease.
METHODS
A total of 126 patients with psoriasis, with no personal history of gastrointestinal symptoms or at the time of the interview, attended at the psoriasis outpatient clinic (Ambulatório Amélio
Marques, Federal University of Uberlândia) were followed prospectively for six months (from May to November 2014) after signing the informed consent form.
For each patient included in the study, a standard form was filled out with data: age, gender, weight, color, height, body mass index (BMI), comorbidities, time of disease evolution, lesion site and dermatological characteristics, degree of severity of psoriasis (PASI score), treatments performed and therapeutic response (data collected by patients' charts at the time of consultation).
Twenty-one volunteers without skin diseases and without personal history of gastrointestinal symptoms, with signed informed consent form, were included as control group. This group was formed by people of socioeconomic level similar to those of the patients and who were accompanying them during the consultations or who had been consulted in another ambulatory near the place.
Patients with psoriasis and controls underwent serology for
PASI score (Psoriasis Area and Severity Index) PASI score is the gold standard for the classification of patients with psoriasis regarding the severity and extension of the dis- ation between these categories was tested by the analysis of the adjusted residues. The adjusted residue has a standard normal distribution, that is, mean equals zero and standard deviation equals one.
Thus, if the adjusted residue is greater than 1.96, in absolute value, it can be said that there is evidence of significant association between the two categories. The larger the residue adjusted, the stronger the association between them.
All analyzes were performed using the IBM SPSS Statistics of the control group. The chi-square test (χ2) showed that there was a statistically significant difference between the groups when severity was related to serology (P=0.045). Table 3 represents the distribution of patients and control group volunteers for serology.
In Table 3 , it can be seen, from the adjusted residues that patients with mild psoriasis and controls are positively associated with negative serology (adjusted residues of 2.9 and 3.2, respectively) and, consequently, negative association with positive serology (adjusted residues of -2.2 and -3.4, respectively). This means that there is a tendency for the patient with negative serology to develop a milder picture of psoriasis. On the other hand, as shown in Table   3 , the adjusted residues show poor evidence when comparing the indeterminate serology with the severity of psoriasis. to a range of actions in the insulin signaling, lipid metabolism and adipogenesis. 6, 7, 14, 15, 16 In our study, the comorbidities most commonly found in psoriatic patients were systemic arterial hypertension, obesity and type 2 diabetes mellitus, findings that are in agreement with the international literature. 
DISCUSSION
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The present study also showed a higher prevalence of lesions in the lower and upper limbs. This is probably due to the fact that plaque psoriasis is the most frequent subtype and most commonly affects the sites of greatest trauma in the human body that are the extensor surfaces of the limbs. der-matched, and tested H. pylori using the Elisa test. 28 The mean prevalence of seropositivity in patients with psoriasis was significantly higher when compared with controls, and the high values correlated with the severity of the disease. response. Activation of T-cell superantigens occurs because H. pylori secretes enterotoxins that bind to a T-cell receptor and induce expression of a skin homing receptor and of a cutaneous lymphocytic antigen in the T-cell. 8, 25, 31 The hypothesis of Fathy et al. is that H. pylori could be at least the triggering factor of psoriasis, particularly the chronic infectious agent that maintains skin disease. 28 However, the etiology of psoriasis seems multifactorial and the idea remains that H. pylori is the trigger for the disease in susceptible individuals. An autoimmune mechanism has been suggested in psoriasis and H. pylori has been associated with autoimmune processes in susceptible patients.
CONCLUSION
Our results agree with those in the literature on the fact that
Helicobacter pylori infection is higher in psoriatic patients and may
interfere with the severity of psoriasis.q
